XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating expenses:    
Research and development $ 646 $ 2,298
General and administrative 1,721 1,880
Total operating expenses 2,367 4,178
Total operating loss (2,367) (4,178)
Other income (expense):    
Interest income 14 4
Interest expense (22) (84)
Total other income (expense) (8) (80)
Net loss (2,375) (4,258)
Preferred stock dividends (96) (285)
Warrant modification (Note 9) (6,622) 0
Net loss applicable to common stockholders $ (9,093) $ (4,543)
Net loss per common share - basic and diluted $ (0.20) $ (0.12)
Weighted average common shares outstanding - basic and diluted 44,975 37,284